Investigation of variant creutzfeldt-jakob disease implicated organ or tissue transplantation in the United Kingdom

Transplantation

Volumn 98, Issue 5, 2014, Pages 585-589

  Molesworth, Anna ^a   Yates, Philip ^b   Hewitt, Patricia E ^c   MacKenzie, Jan ^a   Ironside, James W ^a   Galea, George ^b   Ward, Hester J T ^d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

^d INFORMATION SERVICES DIVISION   (United Kingdom)

Author keywords

Donation; Organ; Public health; Tissue; Transplantation; vCJD

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; CAUSE OF DEATH; CESAREAN SECTION; CONTACT EXAMINATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; GEOGRAPHIC DISTRIBUTION; GRAFT RECIPIENT; HUMAN; INTRAUTERINE INSEMINATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MORTALITY; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PUBLIC HEALTH; RISK ASSESSMENT; TISSUE GRAFT; UNITED KINGDOM; VARIANT CREUTZFELDT JAKOB DISEASE; VARIANT CREUTZFELDT JAKOB DISEASE AGENT; VIRUS TRANSMISSION; CREUTZFELDT-JAKOB SYNDROME; EPIDEMIOLOGY; FEMALE; HEALTH SURVEY; MALE; TRANSMISSION;

CREUTZFELDT-JAKOB SYNDROME; FEMALE; GREAT BRITAIN; HUMANS; MALE; ORGAN TRANSPLANTATION; POPULATION SURVEILLANCE;

EID: 84907597691     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000105     Document Type: Article

References (10)

1. Ward HJT, Everington D, Cousens SN, et al. Risk factors for variant Creutzfeldt-Jakob disease: A case-control study. Ann Neurol 2006; 59: 111.
2. Llewelyn CA, Hewitt PE, Knight RSG, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363: 417.
3. Gill ON, Spencer Y, Richard-Loendt A, et al. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: Large scale survey. BMJ 2013; 347: F5675.
4. Standards and Quality Analytical Team. Risk Assessments for vCJD Transmission via Donated Bone or Tissues. London: Department of Health, UK; 2006.
5. World Health Organisation (WHO). WHO Tables on Tissue Infectivity Distribution in Transmissible Spongiform Encephalopathies. Geneva: WHO; 2010, report no. WHO/EMP/QSM/2010.1.
6. Hewitt PE, Llewelyn CA, Mackenzie J, et al. Creutzfeldt-Jakob disease and blood transfusion: Results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang 2006; 91: 221.
7. Molesworth AM, Smith AJ, Everington D, et al. Risk factors for variant Creutzfeldt-Jakob disease in dental practice: A case-control study. Br Dent J 2012; 213: E19.
8. Standards and Quality Analytical Team.Assessing the Implications for Blood Donors if Recipients are Infected With vCJD. London: Department ofHealth,UK; 2004.
9. Molesworth AM, Cousens SN, Gill ON, et al. Variant Creutzfeldt-Jakob disease in the United Kingdom: A country-wide or local risk? J Epidemiol Community Health 2010; 64: 616.
10. Public Health England & Health Protection Scotland. Public health actions to be taken following a report of a new case of CJD or a person at increased risk of CJD. Colindale (London), 2013 available at http://www. hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb-C/1225960588712. Accessed March 11, 2014.